Poseida Therapeutics

Biotechnology Research • San Diego, California, United States • 101-200 Employees

Company overview

Headquarters	9390 Towne Centre Dr, 200, San Diego, California 92121, US
Phone number	+18587793100
Website	poseida.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Gene Therapy, Prostate Cancer, Oncology, Immunotherapy, Cell Therapy, Immunology, Regenerative Medicine, Genome Engineering, Immuno-Oncology, Gene Editing, Multiple Myeloma, Car-T Cells, T-Cells, Allogeneic, Adoptive Cell Therapy, Cas-Clover™, Cytotoxic T Lymphocytes, Non-Viral, Poseida, Transposon, Piggybac®, Piggybac® Dna Modification System, Tal-Clover™
Founded	2014
Employees	101-200
Socials

Key Contacts at Poseida Therapeutics

Mona Connerney

Senior Director In Vivo Pharmacology

Sarah Thailing

Senior Director, Ir & Corporate Communications

Brian R. Sloat

Director, Gene Therapy

Melissa Johns

Director, Financial Planning And Analysis

Ellen Christie

Associate Director Clinical Operations

Ashley Hammad

Executive Director Of Clinical Sciences

Lu Yao

Director

Christopher Martin

Senior Director

Patrick Hong

Director, Gene Engineering

Cuong Tran

Associate Director Project Management

Poseida Therapeutics Email Formats

Poseida Therapeutics uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@poseida.com), used 90.5% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@poseida.com	91.7%
{last name}{last name}	doedoe@poseida.com	4.8%
{last name}	doe@poseida.com	2.4%
{2char}	{2char}@poseida.com	1.2%

About Poseida Therapeutics

Poseida was acquired by Roche in early 2025 and is now part of the Roche Group. Poseida is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing.

Poseida Therapeutics revenue & valuation

Annual revenue	$150,900,000
Revenue per employee	$863,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$482,800,000
Total funding	$50,000,000

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Director

Senior

Employees by Department

Poseida Therapeutics has 80 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Poseida Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-09-07	14	$50,000,000

Funding Insights

$50,000,000

Total funding amount

$50,000,000

Most recent funding amount

Number of funding rounds

Poseida Therapeutics Tech Stack

Discover the technologies and tools that power Poseida Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Vimeo

Video players

WP Rocket

Caching

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Bootstrap

UI frameworks

Yoast SEO

SEO

Adobe Fonts

Font scripts

Google Tag Manager

Tag managers

Nginx

Reverse proxies

core-js

JavaScript libraries

Frequently asked questions

Poseida Therapeutics is located in San Diego, California, US.

You can reach Poseida Therapeutics at +18587793100.

Poseida Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

Poseida Therapeutics has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Poseida Therapeutics has raised a total of $50,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.